SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LMR PARTNERS LLP | 02/14/2025 | 539.59 K | $40.63 K | 100.00% | 5.83% |
MORGAN STANLEY | 02/14/2025 | 146.44 K | $11.03 K | 0.00% | 1.58% |
YAKIRA CAPITAL MANAGEMENT, INC. | 02/13/2025 | 93.23 K | $7.02 K | -14.06% | 1.01% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 62.50 K | $4.71 K | 0.00% | 0.68% |
HB WEALTH MANAGEMENT, LLC | 01/15/2025 | 50.00 K | $3.87 K | -83.87% | 0.54% |
WALLEYE TRADING LLC | 02/13/2025 | 38.76 K | $2.92 K | 150.00% | 0.42% |
WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 8.66 K | $651 | -44.23% | 0.09% |
UBS GROUP AG | 02/14/2025 | 1.63 K | $122 | 100.00% | 0.02% |
NEWEDGE ADVISORS, LLC | 02/13/2025 | 1.07 K | $80 | 0.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 48 | $4 | 0.00% | 0.00% |
LMR PARTNERS LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
WALLEYE CAPITAL LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
SAB Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 10 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
LMR Partners LLP: 539,588
MORGAN STANLEY: 146,439
Yakira Capital Management, Inc.: 93,230
HB Wealth Management, LLC: 50,001
Walleye Trading LLC: 38,763
WOLVERINE ASSET MANAGEMENT LLC: 8,655
9.50% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 879.43 K shares in the last 24 months. This purchase volume represents approximately $26.38 K in transactions.